4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001415889-22-008769
PRESIDENT & CEO sold 120,000 shares at $37.66 ($4,519,572)
- PRESIDENT & CEO acquired 120,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Marucci Anthony S PRESIDENT & CEO | 2022-08-15 | Option exercise | +75,000 | $2.78 | $208,500 | 102,692 | D |
| Marucci Anthony S PRESIDENT & CEO | 2022-08-15 | Option exercise | +45,000 | $9.02 | $405,743 | 147,692 | D |
| Marucci Anthony S PRESIDENT & CEO | 2022-08-15 | Sale | −120,000 | $37.66 | $4,519,572 | 27,692 | D |
| Derivatives | |||||||
| Marucci Anthony S PRESIDENT & CEO | 2022-08-15 | Option exercise · Incentive Stock Option | −75,000 | 25,000 | D | ||
| Marucci Anthony S PRESIDENT & CEO | 2022-08-15 | Option exercise · Incentive Stock Option | −45,000 | 26,665 | D | ||
| Open-market sales · 120,000 sh · avg $37.66 · $4,519,572 | |||||||
Loading xslF345X03/form4-08172022_010842.xml…